1. Market Overview of Drug of Abuse Testing
1.1 Drug of Abuse Testing Market Overview
1.1.1 Drug of Abuse Testing Product Scope
1.1.2 Market Status and Outlook
1.2 Drug of Abuse Testing Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Drug of Abuse Testing Historic Market Size by Regions (2015-2020)
1.4 Drug of Abuse Testing Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Drug of Abuse Testing Sales Market by Type (2015-2026)
2.1 Global Drug of Abuse Testing Historic Market Size by Type (2015-2020)
2.2 Global Drug of Abuse Testing Forecasted Market Size by Type (2021-2026)
2.3 Amphetamine (AMP) Test
2.4 Methamphetamine (MET) Test
2.5 Opiates/Morphine (OPI) Test
2.6 Barbiturates (BAR) Test
2.7 Benzodiazepines (BZO) Test
2.8 Other types of reagents or strips
3. Covid-19 Impact Drug of Abuse Testing Sales Market by Application (2015-2026)
3.1 Global Drug of Abuse Testing Historic Market Size by Application (2015-2020)
3.2 Global Drug of Abuse Testing Forecasted Market Size by Application (2021-2026)
3.3 Medical screening
3.4 Legal or forensic information
3.5 Employment drug testing
3.6 Sports/athletics testing
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Drug of Abuse Testing Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Drug of Abuse Testing Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Drug of Abuse Testing Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Drug of Abuse Testing Business
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Company Profile
5.1.2 Thermo Fisher Scientific Drug of Abuse Testing Product Specification
5.1.3 Thermo Fisher Scientific Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Siemens Medical Solutions
5.2.1 Siemens Medical Solutions Company Profile
5.2.2 Siemens Medical Solutions Drug of Abuse Testing Product Specification
5.2.3 Siemens Medical Solutions Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Alere
5.3.1 Alere Company Profile
5.3.2 Alere Drug of Abuse Testing Product Specification
5.3.3 Alere Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Firstep Bioresearch
5.4.1 Firstep Bioresearch Company Profile
5.4.2 Firstep Bioresearch Drug of Abuse Testing Product Specification
5.4.3 Firstep Bioresearch Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Biopanda
5.5.1 Biopanda Company Profile
5.5.2 Biopanda Drug of Abuse Testing Product Specification
5.5.3 Biopanda Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 BPC Biosed
5.6.1 BPC Biosed Company Profile
5.6.2 BPC Biosed Drug of Abuse Testing Product Specification
5.6.3 BPC Biosed Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 MP Biomedicals
5.7.1 MP Biomedicals Company Profile
5.7.2 MP Biomedicals Drug of Abuse Testing Product Specification
5.7.3 MP Biomedicals Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Randox Laboratories
5.8.1 Randox Laboratories Company Profile
5.8.2 Randox Laboratories Drug of Abuse Testing Product Specification
5.8.3 Randox Laboratories Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Specialty Diagnostix
5.9.1 Specialty Diagnostix Company Profile
5.9.2 Specialty Diagnostix Drug of Abuse Testing Product Specification
5.9.3 Specialty Diagnostix Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Beckman Coulter
5.10.1 Beckman Coulter Company Profile
5.10.2 Beckman Coulter Drug of Abuse Testing Product Specification
5.10.3 Beckman Coulter Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Field Forensics
5.11.1 Field Forensics Company Profile
5.11.2 Field Forensics Drug of Abuse Testing Product Specification
5.11.3 Field Forensics Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Rapid Labs
5.12.1 Rapid Labs Company Profile
5.12.2 Rapid Labs Drug of Abuse Testing Product Specification
5.12.3 Rapid Labs Drug of Abuse Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Drug of Abuse Testing Market Size (2015-2026)
6.2 North America Drug of Abuse Testing Key Players in North America (2015-2020)
6.3 North America Drug of Abuse Testing Market Size by Type (2015-2020)
6.4 North America Drug of Abuse Testing Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Drug of Abuse Testing Market Size (2015-2026)
7.2 East Asia Drug of Abuse Testing Key Players in North America (2015-2020)
7.3 East Asia Drug of Abuse Testing Market Size by Type (2015-2020)
7.4 East Asia Drug of Abuse Testing Market Size by Application (2015-2020)
8. Europe
8.1 Europe Drug of Abuse Testing Market Size (2015-2026)
8.2 Europe Drug of Abuse Testing Key Players in North America (2015-2020)
8.3 Europe Drug of Abuse Testing Market Size by Type (2015-2020)
8.4 Europe Drug of Abuse Testing Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Drug of Abuse Testing Market Size (2015-2026)
9.2 South Asia Drug of Abuse Testing Key Players in North America (2015-2020)
9.3 South Asia Drug of Abuse Testing Market Size by Type (2015-2020)
9.4 South Asia Drug of Abuse Testing Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Drug of Abuse Testing Market Size (2015-2026)
10.2 Southeast Asia Drug of Abuse Testing Key Players in North America (2015-2020)
10.3 Southeast Asia Drug of Abuse Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Drug of Abuse Testing Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Drug of Abuse Testing Market Size (2015-2026)
11.2 Middle East Drug of Abuse Testing Key Players in North America (2015-2020)
11.3 Middle East Drug of Abuse Testing Market Size by Type (2015-2020)
11.4 Middle East Drug of Abuse Testing Market Size by Application (2015-2020)
12. Africa
12.1 Africa Drug of Abuse Testing Market Size (2015-2026)
12.2 Africa Drug of Abuse Testing Key Players in North America (2015-2020)
12.3 Africa Drug of Abuse Testing Market Size by Type (2015-2020)
12.4 Africa Drug of Abuse Testing Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Drug of Abuse Testing Market Size (2015-2026)
13.2 Oceania Drug of Abuse Testing Key Players in North America (2015-2020)
13.3 Oceania Drug of Abuse Testing Market Size by Type (2015-2020)
13.4 Oceania Drug of Abuse Testing Market Size by Application (2015-2020)
14. South America
14.1 South America Drug of Abuse Testing Market Size (2015-2026)
14.2 South America Drug of Abuse Testing Key Players in North America (2015-2020)
14.3 South America Drug of Abuse Testing Market Size by Type (2015-2020)
14.4 South America Drug of Abuse Testing Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Drug of Abuse Testing Market Size (2015-2026)
15.2 Rest of the World Drug of Abuse Testing Key Players in North America (2015-2020)
15.3 Rest of the World Drug of Abuse Testing Market Size by Type (2015-2020)
15.4 Rest of the World Drug of Abuse Testing Market Size by Application (2015-2020)
16 Drug of Abuse Testing Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.